VAERS reports by lot

GSK Hepatitis B lot 2553X: VAERS reports

21 VAERS reports list lot 2553X as a GSK Hepatitis B vaccine, received between 2024-09-12 and 2026-05-04. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
5%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal1026%
Injection-site / Local reaction1026%
Neurological513%
Cardiac / Cardiovascular513%
Dermatological (non-injection-site)513%
Allergic / Anaphylactic25%
General / Systemic (non-local)25%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Florida4
Louisiana3
Georgia2
Virginia2
Illinois2
Tennessee2
Kansas1
California1
Colorado1
North Carolina1
Iowa1
Connecticut1

Reports by month received

MonthReportsBar
2024-092
2024-104
2024-112
2024-122
2025-011
2025-022
2025-031
2025-061
2025-083
2025-091
2026-031
2026-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis B lots (A–Z): 2KE55 · 2PG39 · 324BY

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.